Related Experiment Video
Updated: Dec 16, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Targeting cellular senescence in cancer and aging: roles of p53 and its isoforms
Jessica Beck1,2, Casmir Turnquist1,3, Izumi Horikawa1
1Laboratory of Human Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Abstract:
Cellular senescence and the associated secretory phenotype (SASP) promote disease in the aged population. Targeting senescent cells by means of removal, modulation of SASP or through cellular reprogramming represents a novel therapeutic avenue for treating cancer- and age-related diseases such as neurodegeneration, pulmonary fibrosis and renal disease. Cellular senescence is partly regulated by the TP53 gene, a critical tumor suppressor gene which encodes 12 or more p53 protein isoforms. This review marks a significant milestone of 40 years of Carcinogenesis publication history and p53 research and 15 years of p53 isoform research. The p53 isoforms are produced through initiation at alternative transcriptional and translational start sites and alternative mRNA splicing. These truncated p53 isoform proteins are endogenously expressed in normal human cells and maintain important functional roles, including modulation of full-length p53-mediated cellular senescence, apoptosis and DNA repair. In this review, we discuss the mechanisms and functions of cellular senescence and SASP in health and disease, the regulation of cellular senescence by p53 isoforms, and the therapeutic potential of targeting cellular senescence to treat cancer- and age-associated diseases.
Insights
Cellular senescence and its secretory phenotype (SASP) contribute to aging diseases. Targeting senescent cells, regulated by p53 isoforms, offers new therapeutic strategies for age-related conditions.
Area of Science:
- Gerontology and Molecular Biology
- Cancer Research
- Cellular Biology
Background:
- Cellular senescence and the senescence-associated secretory phenotype (SASP) are implicated in age-related diseases.
- The TP53 gene, encoding tumor suppressor protein p53, plays a role in regulating cellular senescence.
- p53 isoforms, generated through alternative splicing and translation, are endogenously expressed and have functional roles.
Purpose of the Study:
- To review the mechanisms and functions of cellular senescence and SASP in health and disease.
- To discuss the regulation of cellular senescence by p53 isoforms.
- To explore the therapeutic potential of targeting cellular senescence for cancer- and age-associated diseases.
Main Methods:
- Literature review of cellular senescence, SASP, and p53 research.
- Analysis of p53 isoform generation and function.
- Discussion of therapeutic strategies targeting senescent cells.
Main Results:
- Cellular senescence and SASP contribute to aging and disease.
- p53 isoforms modulate full-length p53 functions like senescence, apoptosis, and DNA repair.
- Targeting senescent cells presents a promising therapeutic avenue.
Conclusions:
- Understanding p53 isoform regulation of cellular senescence is crucial for therapeutic development.
- Targeting cellular senescence offers a novel approach for treating cancer and age-related diseases.
- This review highlights 40 years of p53 research and 15 years of p53 isoform research.
Related Concept Videos
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Replicative Cell Senescence

